Pharmaceutical Prices in the 21st Century

Released on by Zaheer-Ud-Din Babar
preview-18

  • Pharmaceutical Prices in the 21st Century Book Detail

  • Author : Zaheer-Ud-Din Babar
  • Release Date : 2014-12-05
  • Publisher : Springer
  • Genre : Business & Economics
  • Pages : 410
  • ISBN 13 : 3319121693
  • File Size : 64,64 MB
DOWNLOAD BOOK

Pharmaceutical Prices in the 21st Century by Zaheer-Ud-Din Babar PDF Summary

Book Description: This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.

Disclaimer: www.yourbookbest.com does not own Pharmaceutical Prices in the 21st Century books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

Pharmaceutical Prices in the 21st Century

Pharmaceutical Prices in the 21st Century

File Size : 47,47 MB
Total View : 7746 Views
DOWNLOAD

This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emer

The Right Price

The Right Price

File Size : 55,55 MB
Total View : 4264 Views
DOWNLOAD

The prescription drug market -- Proposed solutions for rising drug prices -- Measuring the value of prescription drugs -- Measuring drug value : whose job is it

Reasonable Rx

Reasonable Rx

File Size : 47,47 MB
Total View : 9318 Views
DOWNLOAD

A Real Plan for Making Drugs Affordable–and Promoting Innovation, Too “This book is a necessity for understanding the pharmaceutical industry. Both the plus